QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
Free Trial
NASDAQ:OVAS

OvaScience (OVAS) Stock Price, News & Analysis

→ Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad)
Free OVAS Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$3.31
▼
$3.63
50-Day Range
$8.56
▼
$17.10
52-Week Range
$0.66
▼
$1.52
Volume
590,868 shs
Average Volume
163,131 shs
Market Capitalization
$119.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsSocial Media
OVAS stock logo

About OvaScience Stock (NASDAQ:OVAS)

Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI.

OVAS Stock News Headlines

February 11, 2024 | benzinga.com
General Catalyst Group V LP's Net Worth
December 7, 2023 | finance.yahoo.com
Global In Vitro Fertilization Market Size To Worth USD 39.12 Billion By 2032 | CAGR of 5.5%
April 16, 2024 | Manward Press (Ad)
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
November 4, 2023 | thestreet.com
Ovascience (OVAS) Stock Drops After Pricing Public Offering
June 30, 2023 | finance.yahoo.com
Global Retail Automation Market Size 2023-2027 | Drivers, Product Types, Applications, Growth Analysis and Forecast
June 27, 2023 | markets.businessinsider.com
TMRW Life Sciences Names Louis Villalba Chief Executive Officer
June 22, 2023 | marketwatch.com
IVF Devices and Consumables Market Research Report 2023 Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2030
June 1, 2023 | finance.yahoo.com
OcuTerra Appoints Bill Steinkrauss as Chief Financial Officer
April 16, 2024 | The Bull Report (Ad)
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
May 15, 2023 | marketwatch.com
IVF Market Business Approaches by 2030
April 14, 2023 | marketwatch.com
Research Shows: Semen Analysis Systems Market Growth, Share, Trends, Size, Revenue, Opportunities and Demand – 2030
March 27, 2023 | marketwatch.com
IVF Market Size and Forecast till 2031
March 27, 2023 | marketwatch.com
Global InVitro Fertilization (IVF) Market Size by Application (Male Infertility, Female Infertility) Forecast from 2023 to 2028
March 27, 2023 | marketwatch.com
Donor Egg IVF (In-Vitro Fertilization) Market Size, Share, Outlook and Forecast to 2031
March 26, 2023 | marketwatch.com
IVF Instruments Market 2023: Strategies of Top Players by 2029
March 19, 2023 | marketwatch.com
IVF Market- Industry Fluctuation till 2029
March 14, 2023 | marketwatch.com
IVF Devices and Consumables Market Application, Product, Sales and Forecast 2023-2028
March 12, 2023 | marketwatch.com
Global IVF Devices and Consumables Market Analysis By Type Technology End-Use By Region By Country and Forecast 2023 to 2030 By VMReports
February 25, 2023 | marketwatch.com
IVF Market Size 2023: Reliable Business Demand, and New Strategies Forecast 2028
February 25, 2023 | marketwatch.com
In-Vitro Fertilization (IVF) Market 2023 : Incredible Possibilities, Growth Analysis and Forecast To 2028
February 19, 2023 | marketwatch.com
Global IVF Market Application, Product Segment, Analysis and Forecast 2023-2030 Report By VMReports
February 19, 2023 | marketwatch.com
InVitro Fertilization (IVF) Market is Booming Worldwide with Top Countries Data
February 18, 2023 | marketwatch.com
Global In-Vitro Fertilization (IVF) Market 2023 Industry Trends, Regional Developments and Competitive Landscape Analysis Report 2030 By VMReports
January 18, 2023 | marketwatch.com
IVF Market Size: Overview, Share, Trends with Current Market Scenario, 2027
December 22, 2022 | marketwatch.com
Donor Egg IVF Treatment Market Growth and Global Share 2023 | Developing Regions, Emerging Trends and Industry Size Forecast to 2029
December 16, 2022 | marketwatch.com
In Vitro Fertilization Market : Latest Trends, Size, Key Players, Revenue and Forecast 2028
December 6, 2022 | marketwatch.com
IVF Market Analysis Report 2023 Along with Statistics Figures, Forecasts till 2027
See More Headlines
Receive OVAS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OvaScience and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OVAS
CUSIP
N/A
CIK
1544227
Web
www.ovascience.com
Phone
(734) 845-9000
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-50,970,000.00
Net Margins
-10,128.37%
Pretax Margin
N/A
Return on Equity
-47.06%
Return on Assets
-42.39%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.62
Quick Ratio
12.62

Sales & Book Value

Annual Sales
$290,000.00
Price / Sales
412.66
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.80 per share
Price / Book
1.86

Miscellaneous

Outstanding Shares
35,830,000
Free Float
N/A
Market Cap
$119.67 million
Optionable
Not Optionable
Beta
3.11
7 Stocks to Own Before the 2024 Election Cover
7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Louis J. Arcudi
    President, Chief Executive Officer & Director
  • Jennifer Minai-Azary
    Chief Financial & Accounting Officer
  • Christophe Arbet-Engels
    Chief Medical Officer
  • Thomas Hoover
    Chief Business Officer
  • Denise Dorigo Jones
    Vice President-Human Resources

Key Competitors

View All Competitors

OVAS Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of OvaScience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OvaScience investors own include Synergy Pharmaceuticals (SGYP), OPKO Health (OPK), Gilead Sciences (GILD), TherapeuticsMD (TXMD), Melinta Therapeutics (MLNT), Bausch Health Companies (BHC), Bed Bath & Beyond (BBBY), GW Pharmaceuticals (GWPH), (RLYP) (RLYP) and Trevena (TRVN).

This page (NASDAQ:OVAS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Can't believe it's happening again
Manward Press
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange